Carter Cliff - Founder & CEO @ Vascugen - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Founded Organizations

CB Rank (Person)

295,400

Primary Job Title Founder & CEO
Primary Organization
Vascugen

Location Madison, Wisconsin, United States
Regions Great Lakes, Midwestern US
Gender Male

LinkedIn View on LinkedIn

Carter Cliff is a Founder and CEO at Vascugen. He was a former Director of Business Development at Cellular Dynamics International. He attended UT Southwestern Medical Center and the New Mexico Institute of Mining and Technology.

Jobs

Number of Current Jobs

Number of Past Jobs

Carter Cliff

has

current jobs including

Founder & CEO

Vascugen

Co-Founder

Dianomi Therapeutics

, and

Co-Founder

RPRD Diagnostics

. Additionally,

Carter Cliff

has had

past job as the

Director Business Development

Cellular Dynamics International

Vascugen Founder & CEOJun 2017
Dianomi Therapeutics Co-FounderMar 2017
RPRD Diagnostics Co-FounderOct 2016
Opsis Therapeutics Co-FounderJul 2016

Organization Name	Title At Company	Start Date	End Date
Cellular Dynamics International	Director Business Development	2010	2016

Related Hubs

Hub Name	CB Rank (Hub)
Great Lakes Seed Stage Companies With More Than $1M in Revenue	35,488
Great Lakes Seed Stage Companies	9,477
Private Madison Companies	35,129
Great Lakes Seed Stage Companies With More Than 10 Employees	23,809
Wisconsin Seed Stage Companies	81,776
Wisconsin Health Care Companies	24,084
Madison Companies With More Than 10 Employees	43,907
Midwestern US Seed Stage Companies With Fewer Than 50 Employees	10,312
Midwestern US Seed Stage Companies With Less Than $50M in Revenue	22,044
Private Wisconsin Companies (Top 10K)	4,579

Education

Carter Cliff

studied at

New Mexico Tech

and

University of Texas Southwestern Medical School

New Mexico Tech BSChemistry & Biology19941998
University of Texas Southwestern Medical School DegreeCell & Molecular Biology19992001

Recent News and Activity

There is no recent news or activity for this profile.